Orlando, Fla. (January 3, 2020) – Help is here for 29 million wheezy kids and the 100 million Americans who suffer from respiratory illnesses.
Next week, Orlando-based AireHealth is launching sales of its new portable nebulizer and the AireHealth Asthma App, giving patients who suffer through respiratory illnesses key tools for a healthier life.
Both key milestones are being launched at CES in Las Vegas, starting January 7.
The potential of this new technology was an integral part of the criteria to be chosen as a featured startup in Eureka Park, a segment of CES reserved for only 1,200 of the most promising startup businesses nationwide.
“This is what we’ve been working toward for more than a year, to get this technology into the hands of the children who need it,” says Stacie Ruth, CEO, AireHealth. “To be selected to be part of Eureka Park to make our product and app launch is quite an honor.”
Startups can apply to be showcased only once in Eureka Park, and each business must follow strict requirements. For instance, startups exhibiting in Eureka Park this year must have a finished, branded product that launched after January 1, 2019. It must be “innovative with the potential to make a profound impact on the market” and the product would benefit consumers.
AireHealth’s FDA-cleared Class II nebulizer provides a new way for patients with asthma and other respiratory illnesses to receive much needed medicine. Today, they either use an inhaler, which can pose proper use problems for some, or a large machine that is not portable.
AireHealth’s nebulizer is the size of a deck of cards and is designed to provide an accurate dosage of prescribed medication every time, faster than today’s standard nebulizer treatments.
The new AireHealth Asthma App, hitting app stores this month, is structured to help guide patients and caregivers through their illness.
It provides alerts for low air quality conditions, and the app also contains industry respected KidsHealth® education and information about asthma tailored to kids, teens and parents to keep patients and their caregivers confident and informed. Triggers and symptoms can be logged to fully understand the personal impacts of asthma and helps someone with the illness better understand when an attack or an escalation of symptoms may occur. Reminders on medicines can be structured based on each individual’s needs and can be shared across multiple, invited caregivers and exported to your physician.
“The key to controlling asthma is being proactive in the care of the patient,” Ruth says. “This app gives patients and caregivers a tool for communication, giving them peace of mind as they navigate their lives.”
For more information media should contact –
AireHealth: Media Relations, firstname.lastname@example.org
About AireHealth: AireHealth’s portable nebulizer and connected care mobile application helps 100+ million people in the U.S. living with respiratory illness (including 29+ million “wheezy” kids) become more proactive with their respiratory care in an effort to improve outcomes and lower the overall cost of respiratory care. AireHealth’s FDA cleared Class 2 portable nebulizer is designed to deliver medicine directly to a patient’s lungs where it is most effective. Also, AireHealth’s connected care mobile application provides patients with medication reminders and asthma trigger alerts where and when patients need them.
Together, the FDA cleared nebulizer and connected care application helps patients take a more proactive approach to managing their respiratory care and helps them achieve their goal of improving treatment outcomes and lowering costs. For more information, please visit Aire.Health.
About the UCF Business Incubation Program: The University of Central Florida Business Incubation Program is a community resource that provides early-stage companies with the tools, training and infrastructure to become financially stable, high growth/impact enterprises. Since 1999, this award-winning program has helped over 390 local startup companies reach their potential faster by providing vital business development resources.
With seven facilities throughout the region, the UCF Business Incubation Program is an economic development partnership between the University of Central Florida, the Corridor, Orange, Osceola, Seminole and Volusia counties, and the cities of Apopka, Kissimmee, Orlando and Winter Springs. For the 2016/17 and 2017 /18 fiscal years, the activities of these participating firms have helped sustain more than 6,275 local jobs and have had a cumulative impact of more than $888 million on regional GDP and more than $1.59 billion on regional sales. During the same period, the program has returned $12.03 for every $1 invested in the program. For more information, visit Incubator.UCF.edu.